BioStem Technologies BSEM Growth Metrics (2025-2026)

NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

BioStem Technologies Quarterly Growth Metrics

Periods 4 quarters
Latest Jun 2026

BioStem Technologies reported revenue growth of -27.95% for the quarter ended Jun 2026. These growth metrics cover 4 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 0.00%-66.67%
Total Debt Growth (1y) -26.97%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 102.12%
Revenue (QoQ) -31.34%28.75%
Revenue Growth (1y) -61.57%-27.95%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.00M0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.02M-0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -0.72%12.12%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 163.90%
Operating Margin (QoQ) 0.00M0.00M
Operating Margin Growth (1y) -0.02M-0.01M
Operating Income (QoQ)Op. Inc (QoQ) -97.85%5.45%
Operating Income Growth (1y)Op. Inc Growth (1y) -269.25%-7,550.13%
Net Margin (QoQ) 0.00M0.00M
Net Margin Growth (1y) -0.02M-0.01M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -99.73%-1.72%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -325.68%-84,631.80%
Net Income (QoQ) -99.73%-1.72%
Net Income Growth (1y) -325.68%-84,631.80%
Net Cash Flow (QoQ)NCF (QoQ) 8.58%64.69%
Net Cash Flow Growth (1y)NCF Growth (1y) -512.57%-234.15%
Income After Tax (QoQ) -99.84%-1.72%
Income After Tax Growth (1y) -232.57%-84,631.80%
Gross Profit (QoQ) -31.99%28.76%
Gross Profit Growth (1y) -75.13%-52.90%
Gross Margin (QoQ) -90.001.00
Gross Margin Growth (1y) 0.00M0.00M
Free Cash Flow (QoQ)FCF (QoQ) 12.31%-579.63%
Free Cash Flow Growth (1y)FCF Growth (1y) -119.43%-217.60%
FCF Margin (QoQ) 0.00M-0.01M
FCF Margin Growth (1y) 0.00M-0.01M
EPS (Diluted) (QoQ) -37.48%
EPS (Diluted) Growth (1y) -114,351.58%
EPS (Basic) (QoQ) 1.91%
EPS (Basic) Growth (1y) -81,612.66%
EBT (QoQ) -96.63%-1.72%
EBT Margin (QoQ) 0.00M0.00M
EBT Margin Growth (1y) -0.02M-0.01M
EBT Growth (1y) -267.02%-5,141.42%
EBIT (QoQ) -97.85%5.45%
EBIT Margin (QoQ) 0.00M0.00M
EBIT Margin Growth (1y) -0.02M-0.01M
EBIT Growth (1y) -269.25%-7,550.13%
EBITDA Margin (QoQ) 0.00M0.00M
EBITDA Margin Growth (1y) -0.02M-0.01M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 33.10%-570.92%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -120.26%-202.14%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -101.80%99.63%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -9,018.27%83.11%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -53.63%-49.19%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 29.42%
Capital Expenditures (QoQ)Capex (QoQ) 501.80%3,428.82%
Capital Expenditures Growth (1y)Capex Growth (1y) 98.91%-90.98%
Assets (QoQ) 10.11%-11.37%
Assets Growth (1y) -14.22%

BioStem Technologies Growth Metrics API

Pull BioStem Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BSEM&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY